InvestorsHub Logo
Followers 26
Posts 3558
Boards Moderated 0
Alias Born 11/12/2018

Re: mrmainstreet post# 312001

Saturday, 11/28/2020 12:01:24 PM

Saturday, November 28, 2020 12:01:24 PM

Post# of 430599
Mrmainstreet, JT could launch an AG and immediately reduce Hikma sales by 50%. For some reason, JT and team don’t feel this option is necessary yet. Why? I don’t know but the AG is the poison pill solution if the current strategy doesn’t pan out. Personally, I would like to see an immediate AG launch and an injunction request from AMRN. I’m pretty sure both are coming. I think the evidence of scripts being switched and the formulary tier changes for Vascepa is the evidence AMRN are gathering for injunctive relief for an irreparable harm claim. IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News